Green Pine Capital Partners has been investing since 1997, is rooted in Shenzhen's hard-tech scene, and is known for making early bets on companies like BGI, 光启, and 奥比中光, along with a public stance against investing in P2P during that industry's boom; it's led by a science-minded team rather than a finance-first one, including founding partner 厉伟, a chemistry graduate, and has evolved from backing BGI in 2008 to running a dedicated Shenzhen cell and gene therapy fund by 2024. The firm also runs its own innovation incubator, hosts events like the 松禾资本春季论坛 to connect founders and investors, and points to a track record of 36 standout exits from roughly RMB 8 billion under management.